The DOI matches its Crossref record; 80 of the 80 references it cites were found in a registry or an index.
Nitric Oxide Insufficiency, Platelet Activation, and Arterial Thrombosis
Abstract
Abstract—Nitric oxide (NO) was originally discovered as a vasodilator product of the endothelium. Over the last 15 years, this vascular mediator has been shown to have important antiplatelet actions as well. By activating guanylyl cyclase, inhibiting phosphoinositide 3-kinase, impairing capacitative calcium influx, and inhibiting cyclooxygenase-1, endothelial NO limits platelet activation, adhesion, and aggregation. Platelets are also an important source of NO, and this platelet-derived NO pool limits recruitment of platelets to the platelet-rich thrombus. A deficiency of bioactive NO is associated with arterial thrombosis in animal models, individuals with endothelial dysfunction, and patients with a deficiency of the extracellular antioxidant enzyme glutathione peroxidase-3. This enzyme catalyzes the reduction of hydrogen and lipid peroxides, which limits the availability of these reactive oxygen species to react with and inactivate NO. The complex biochemical reactions that underlie the function and inactivation of NO in the vasculature represent an important set of targets for therapeutic intervention for the prevention and treatment of arterial thrombotic disorders.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“NO has a vasodilating effect and inhibits platelet aggregation [63].”
From Mediterranean Diet as an Antioxidant: The Impact on Metabolic Health and Overall Wellbeing (2021) · cites this paper as [63]
In the citing paper
“NO has a vasodilating effect and inhibits platelet aggregation [63].”
From Mediterranean Diet as an Antioxidant: The Impact on Metabolic Health and Overall Wellbeing (2021) · cites this paper as [63]
In the citing paper
“The activation of platelets is mediated by NO through the soluble guanylate cyclase (sGC) pathway.”
From Recent advances in thromboresistant and antimicrobial polymers for biomedical applications: just say yes to nitric oxide (NO) (2016) · cites this paper as [121]
In the citing paper
“The NO produced by eNOS contributes to the thromboresistant properties of the endothelial lining of blood vessels by inhibiting platelet activation.”
From Recent advances in thromboresistant and antimicrobial polymers for biomedical applications: just say yes to nitric oxide (NO) (2016) · cites this paper as [121]
In the citing paper
“In addition, the cGMP increases cyclic adenosine monophosphate (cAMP) levels indirectly through phosphodiesterase III, which will also decrease the intracellular calcium concentration.”
From Recent advances in thromboresistant and antimicrobial polymers for biomedical applications: just say yes to nitric oxide (NO) (2016) · cites this paper as [121]
In the citing paper
“The NO activated sGC ultimately results in reduced intracellular calcium, inhibition of platelet phosphoinositide 3-kinase (PI3), and reduced affinity as well as number of surface membrane fibrinogen binding sites on platelets (GPIIb/IIIa).117,121–126”
From Recent advances in thromboresistant and antimicrobial polymers for biomedical applications: just say yes to nitric oxide (NO) (2016) · cites this paper as [121]
Citations
Cites
Furchgott, R. F., & Zawadzki, J. V. (1980) · Nature · doi:10.1038/288373a0 · Cited by 12,064
Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor
Palmer, R. M. J., Ferrige, A. G., & Moncada, S. (1987) · Nature · doi:10.1038/327524a0 · Cited by 10,704
Biochemistry of nitric oxide and its redox-activated forms
Stamler, J. S., Singel, D. J., & Loscalzo, J. (1992) · Science · doi:10.1126/science.1281928 · Cited by 2,744
Self-citationUpregulation of Endothelial Nitric Oxide Synthase by HMG CoA Reductase Inhibitors
Laufs, U., Fata, V. L., Plutzky, J., & Liao, J. K. (1998) · Circulation · doi:10.1161/01.cir.97.12.1129 · Cited by 1,837
ENDOGENOUS NITRIC OXIDE INHIBITS HUMAN PLATELET ADHESION TO VASCULAR ENDOTHELIUM
Radomski, M. W., Palmer, R. M. J., & Moncada, S. (1987) · The Lancet · doi:10.1016/s0140-6736(87)91481-4 · Cited by 1,437
Rubbo, H., Radí, R., Trujillo, M., Telleri, R., Kalyanaraman, B., Barnes, S., KIRK, M. C., & Freeman, B. Α. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47160-8 · Cited by 1,350
Nitric oxide circulates in mammalian plasma primarily as an S-nitroso adduct of serum albumin.
Stamler, J. S., Jaraki, O., Osborne, J., Simon, D. I., Keaney, J., Vita, J., Singel, D., Valeri, C. R., & Loscalzo, J. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.16.7674 · Cited by 1,238
Self-citationIgnarro, L. J., Byrns, R. E., Buga, G. M., & Wood, K. S. (1987) · Circulation Research · doi:10.1161/01.res.61.6.866 · Cited by 1,164
Radomski, M. W., Palmer, R. M. J., & Moncada, S. (1987) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1987.tb11310.x · Cited by 811
Katsuki, S., Arnold, W. P., Mittal, C. K., & Murad, F. (1977) · PubMed · Cited by 700
Flagged first, then by citations
Research works printed but not linked: 18
- Cunningham M, Loscalzo J. Nitroprusside can induce clinically important platelet dysfunction only detectable in vitro by incubation with reduced thiol. Clin Res. 1985;33:337A.
- 10.1161/circ.83.6.1904015 · DOI
- 10.1161/res.61.6.2890446 · DOI
- 10.1161/res.65.3.2548765 · DOI
- 10.1161/res.65.3.2504509 · DOI
- Keaney JF Jr, Stamler JS, Scharftstein J, Folts JD, Loscalzo J. Nitric oxide forms a stable adduct with serum albumin that has potent antiplatelet properties in vivo. Clin Res. 1992;40:194A. Abstract.
- 10.1161/res.81.5.865 · DOI
- Pigazzi A, Fabian A, Johnson J, Upchurch GR, Loscalzo J. Identification of nitric oxide synthases in human megakaryocytes and platelets. Circulation. 1995;92:I-365.
- 10.1161/res.84.12.1416 · DOI
- 10.1161/circ.94.10.2434 · DOI
- 10.1161/str.31.10.2442 · DOI
- 10.1161/circ.97.12.1129 · DOI
- 10.1161/hyp.35.4.904 · DOI
- 10.1161/circ.94.12.3109 · DOI
- 10.1161/circ.98.15.1481 · DOI
- 10.1161/atvb.19.8.2017 · DOI
- Voetsch B, Bierl C, Damasceno BP, Annichino-Bizzacchi JM, Arruda VR, Loscalzo J. A novel promoter polymorphism in the plasma glutathione peroxidase gene associated with arterial ischemic stroke in the young. Circulation. 2000;102:II-704.
- 10.1161/atvb.18.8.1248 · DOI
Cited by
Sorted by citations
Items 201–300 of 611
Lipid-based carriers for controlled delivery of nitric oxide
Elnaggar, M. A., Subbiah, R., Han, D. K., & Joung, Y. K. (2017) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2017.1285904 · Cited by 37
Oxidative stress, the renin-angiotensin system, and atherosclerosis
Landmesser, U. (2003) · European Heart Journal Supplements · doi:10.1016/s1520-765x(03)90057-5 · Cited by 37
IL-37 Attenuates Platelet Activation and Thrombosis Through IL-1R8 Pathway
Chen, Y., Hong, J., Zhong, H., Zhao, Y., Li, J., Shen, W., Luo, X., Shi, H., Hu, L., Liu, J., et al. (2023) · Circulation Research · doi:10.1161/circresaha.122.321787 · Cited by 37
Haouari, M. E. (2019) · Current Medicinal Chemistry · doi:10.2174/0929867324666171005114456 · Cited by 37
Caio‐Silva, W., Dias, D. D. S., Junho, C. V. C., Panico, K., Neres-Santos, R. S., Pelegrino, M. T., Pieretti, J. C., Seabra, A. B., Angelis, K. D., & Carneiro‐Ramos, M. S. (2020) · BioMed Research International · doi:10.1155/2020/1605358 · Cited by 36
McIlhenny, S. E., Zhang, P., Tulenko, T. N., Comeau, J. A., Fernandez, S., Policha, A., Ferroni, M. C., Faul, E. J., Bagameri, G., Shapiro, I. M., et al. (2013) · Journal of Tissue Engineering and Regenerative Medicine · doi:10.1002/term.1645 · Cited by 36
Cardiovascular Effects of Losartan and Its Relevant Clinical Application
Xu, F., Mao, C., Hu, Y., Rui, C., Xu, Z., & Zhang, L. (2009) · Current Medicinal Chemistry · doi:10.2174/092986709789178046 · Cited by 36
Risk of venous and arterial thromboembolic events associated with VEGFR-TKIs: a meta-analysis
Liu, B., Ding, F., Zhang, D., & Wei, G. (2017) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-017-3386-6 · Cited by 35
Roberts, W., Michno, A., Aburima, A. A., & Naseem, K. M. (2009) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2009.03619.x · Cited by 35
The Potential of Flavanol and Procyanidin Intake to Influence Age-Related Vascular Disease
Holt, R. R., Heiß, C., Kelm, M., & Keen, C. L. (2012) · Journal of Nutrition in Gerontology and Geriatrics · doi:10.1080/21551197.2012.702541 · Cited by 35
Rogers, N. M., Seeger, F., Garcin, E. D., Roberts, D. D., & Isenberg, J. S. (2014) · Frontiers in Physiology · doi:10.3389/fphys.2014.00134 · Cited by 39
Yokomizo, S., Kopp, T., Roeßing, M., Morita, A., Lee, S., Cho, S., Ogawa, E., Komai, E., Inoue, K., Fukushi, M., et al. (2024) · Stroke · doi:10.1161/strokeaha.123.045358 · Cited by 34
Vasomotor Regulation of Coronary Microcirculation by Oxidative Stress: Role of Arginase
Kuo, L., & Hein, T. W. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00237 · Cited by 33
Potential therapeutic action of nitrite in sickle cell disease
Wajih, N., Basu, S., Jailwala, A., Kim, H. W., Ostrowski, D., Perlegas, A. S., Bolden, C. A., Buechler, N. L., Gladwin, M. T., Caudell, D. L., et al. (2017) · Redox Biology · doi:10.1016/j.redox.2017.05.006 · Cited by 33
Konopińska, K. K., Schmidt, N. J., Hunt, A. P., Lehnert, N., Wu, J., Xi, C., & Meyerhoff, M. E. (2018) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.8b05917 · Cited by 33
Noncoding RNAs in Vascular Aging
Cao, Q., Wu, J., Wang, X., & Song, C. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/7914957 · Cited by 33
Peripheral Arterial Disease: A Review of Disease Awareness and Management
Watson, K., Watson, B. D., & Pater, K. S. (2006) · The American Journal of Geriatric Pharmacotherapy · doi:10.1016/j.amjopharm.2006.12.006 · Cited by 33
Endothelial vasodilatation in newborns is related to body size and maternal hypertension
Touwslager, R. N. H., Houben, A. J. H. M., Gielen, M., Zeegers, M. P., Stehouwer, C. D. A., Zimmermann, L. J. I., Kessels, A. G. H., Gerver, W. M., Blanco, C. E., & Mulder, A. (2011) · Journal of Hypertension · doi:10.1097/hjh.0b013e32834d75c6 · Cited by 33
Ovechkin, A. V., Lominadze, D. G., Sedoris, K. C., Gozal, E., Robinson, T., & Roberts, A. M. (2005) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01302.2004 · Cited by 33
Yang, Y., Lu, M., Wang, C., Song, M., Li, C., Chen, M., Zhou, J., & Mei, C. (2020) · Basic Research in Cardiology · doi:10.1007/s00395-020-0789-z · Cited by 32
Asif, A. R., Oellerich, M., Armstrong, V. W., Hecker, M., & Cattaruzza, M. (2009) · Journal of Proteome Research · doi:10.1021/pr800998k · Cited by 32
Comparative angioprotective effects of magnesium compounds
Kharitonova, M. V., Iezhitsa, I. N., Zheltova, A. A., Ozerov, A. A., Спасов, А. А., & Skalny, A. V. (2014) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2014.06.026 · Cited by 32
Endothelial Cell Aging: How miRNAs Contribute?
Yamakuchi, M., & Hashiguchi, T. (2018) · Journal of Clinical Medicine · doi:10.3390/jcm7070170 · Cited by 32
Antiplatelet Agents for the Prevention of Cardiovascular Disease in Diabetes Mellitus
Colwell, J. A. (2004) · American Journal of Cardiovascular Drugs · doi:10.2165/00129784-200404020-00003 · Cited by 32
Young male smokers have altered platelets and endothelium that precedes atherosclerosis
Casey, R. G., Joyce, M., Roche‐Nagle, G., Cox, D. M., & Bouchier‐Hayes, D. J. (2004) · Journal of Surgical Research · doi:10.1016/s0022-4804(03)00343-3 · Cited by 31
Fledderus, J., Vanchin, B., Rots, M. G., & Krenning, G. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11020103 · Cited by 31
Nitric Oxide–Eluting Polyurethanes — Vascular Grafts of the Future?
Verma, S., & Marsden, P. A. (2005) · New England Journal of Medicine · doi:10.1056/nejmcibr052030 · Cited by 31
Gasotransmitters and platelets
Truss, N. J., & Warner, T. D. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.07.001 · Cited by 31
Qin, X., Hu, W., Song, W., Blair, P. S., Wu, G., Hu, X., Song, Y., Bauer, S. M., Feelisch, M., Leopold, J. A., et al. (2009) · American Journal of Hematology · doi:10.1002/ajh.21363 · Cited by 31
Self-citationLu, Y., Lian, S., Ye, Y., Yu, T., Liang, H., Cheng, Y., Xie, J., Zhu, Y., Xie, X., Yu, S., et al. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.10.020 · Cited by 31
Platelet-derived NO slows thrombus growth on a collagen type III surface.
Williams, R. H., & Nollert, M. U. (2004) · Thrombosis Journal · doi:10.1186/1477-9560-2-11 · Cited by 31
AGEING, OESTROGEN, PLATELETS AND THROMBOTIC RISK
Miller, V. M., Jayachandran, M., & Owen, W. G. (2007) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2007.04685.x · Cited by 31
Ruiz, A. P., Montes, R., Velasco, F., López-Pedrera, C., Páramo, J. A., Orbe, J., Hermida, J., & Rocha, E. A. V. (2002) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1613355 · Cited by 31
Drug Insight: statins for nonischemic heart failure—evidence and potential mechanisms
Lipinski, M. J., Abbate, A., Fuster, V., & Vetrovec, G. W. (2007) · Nature Clinical Practice Cardiovascular Medicine · doi:10.1038/ncpcardio0855 · Cited by 31
Methotrexate and cardiovascular prevention: an appraisal of the current evidence
Mangoni, A. A., Sotgia, S., Zinellu, A., Carru, C., Pintus, G., Damiani, G. B., Erre, G. L., & Tommasi, S. (2023) · Therapeutic Advances in Cardiovascular Disease · doi:10.1177/17539447231215213 · Cited by 31
Eplerenone improves vascular function and reduces platelet activation in diabetic rats.
Schäfer, A., Vogt, C., Fraccarollo, D., Widder, J., Flierl, U., Hildemann, S. K., Ertl, G., & Bauersachs, J. K. (2010) · PubMed · Cited by 30
NO in Viral Infections: Role and Development of Antiviral Therapies
Sodano, F., Gazzano, E., Fruttero, R., & Lazzarato, L. (2022) · Molecules · doi:10.3390/molecules27072337 · Cited by 30
Do Statins have a Role in Reduction/Prevention of Post‐PCI Restenosis?
Prasad, K. (2011) · Cardiovascular Therapeutics · doi:10.1111/j.1755-5922.2011.00302.x · Cited by 32
Nonlipid-lowering effects of statins
Sorrentino, S. A., & Landmesser, U. (2005) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-005-0031-1 · Cited by 31
N-Ethylmaleimide-sensitive factor: a redox sensor in exocytosis
Lowenstein, C. J., & Tsuda, H. (2006) · Biological Chemistry · doi:10.1515/bc.2006.173 · Cited by 30
Carrizzo, A., Iside, C., Nebbioso, A., Carafa, V., Damato, A., Sciarretta, S., Frati, G., Nonno, F. D., Valenti, V., Ciccarelli, M., et al. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04429-5 · Cited by 29
Castelli, R., Bergamaschini, L. C., Sailis, P., Pantaleo, G., & Porro, F. (2007) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/1076029607308860 · Cited by 29
Damodaran, V. B., Leszczak, V., Wold, K. A., Lantvit, S. M., Popat, K. C., & Reynolds, M. M. (2013) · RSC Advances · doi:10.1039/c3ra45521a · Cited by 29
Wang, C., Yang, F., Xu, Z., Shi, D., Chen, D., Dai, J., Gu, N., & Jiang, Q. (2013) · Thrombosis Research · doi:10.1016/j.thromres.2012.11.002 · Cited by 28
Ladurner, A., Atanasov, A. G., Heiß, E. H., Baumgartner, L., Schwaiger, S., Rollinger, J. M., Stuppner, H., & Dirsch, V. M. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2012.06.029 · Cited by 28
Park, K. W., Park, J. J., Kang, J., Jeon, K., Kang, S., Han, J., Lee, S. E., Yang, H., Lee, H., Kang, H., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0052779 · Cited by 28
Paixão-Cavalcante, D., Kuniyoshi, A. K., Portaro, F. C. V., da Silva, W. D., & Tambourgi, D. V. (2015) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0003419 · Cited by 28
Regulation of protein kinase C by nitroarachidonic acid: Impact on human platelet activation
Bonilla, L., O’Donnell, V. B., Clark, S., Rubbo, H., & Trostchansky, A. (2013) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2013.03.001 · Cited by 29
Sickle Cell Disease: New Insights into Pathophysiology and Treatment
Inati, A. C., Koussa, S., Taher, A. T., & Perrine, S. P. (2008) · Pediatric Annals · doi:10.3928/00904481-20080501-07 · Cited by 28
Ren, Z., Ren, P., Yang, B., Liao, J., Liu, S.-Z., Lu, D., Wei, X., Liu, L.-R., & Dong, Q. G. (2017) · Andrologia · doi:10.1111/and.12777 · Cited by 28
Particulate Pollution and Endothelial Function
Rajagopalan, S., Sun, Q., & Chen, L. (2005) · Circulation · doi:10.1161/circulationaha.105.540872 · Cited by 28
Stojak, M., Kaczara, P., Motterlini, R., & Chłopicki, S. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.09.005 · Cited by 27
Ghosh, A., Sumi, M. P., Tupta, B., Okamoto, T., Aulak, K. S., Tsutsui, M., Shimokawa, H., ERZURUM, S. C., & Stuehr, D. J. (2022) · Redox Biology · doi:10.1016/j.redox.2022.102478 · Cited by 27
Mononuclear cell therapy reverts cuff-induced thrombosis in apolipoprotein E-deficient mice
Freitas‐Lima, L. C., Porto, M. L., Campagnaro, B. P., Tonini, C. L., Nogueira, B. V., Pereira, T. M., Vasquez, E. C., & Meyrelles, S. S. (2012) · Lipids in Health and Disease · doi:10.1186/1476-511x-11-96 · Cited by 27
Watt, J., Ewart, M., Greig, F. H., Oldroyd, K. G., Wadsworth, R. M., & Kennedy, S. (2012) · Thrombosis Research · doi:10.1016/j.thromres.2012.03.024 · Cited by 27
Umar, S., Asif, M., Sajad, M., Ansari, M. M., Hussain, U., Ahmad, W., Siddiqui, S. A., Ahmad, S., & Khan, H. A. (2012) · International Journal of Drug Development and Research · Cited by 27
Soluble Guanylyl Cyclase Activation With HMR1766 Attenuates Platelet Activation in Diabetic Rats
Schäfer, A., Flierl, U., Kobsar, A. L., Eigenthaler, M., Ertl, G., & Bauersachs, J. K. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000249407.92147.12 · Cited by 27
Mohammadi, M. R., Talasaz, A. H., & Alidoosti, M. (2016) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2016.06.009 · Cited by 26
Fluid-structure coupled biotransport processes in aortic valve disease
Sadrabadi, M. S., Hedayat, M., Borazjani, I., & Arzani, A. (2021) · Journal of Biomechanics · doi:10.1016/j.jbiomech.2021.110239 · Cited by 26
Shamova, E. V., Бичан, О. Д., Drozd, E. S., Gorudko, I. V., Чижик, С. А., Шумаев, К. Б., Cherenkevich, S. N., & Vanin, A. F. (2011) · BIOPHYSICS · doi:10.1134/s0006350911020278 · Cited by 26
Sugiyama, T., & Michel, T. M. (2009) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00767.2009 · Cited by 26
Genetics of thrombophilia: impact on atherogenesis
Voetsch, B., & Loscalzo, J. (2004) · Current Opinion in Lipidology · doi:10.1097/00041433-200404000-00006 · Cited by 26
Self-citationRoles and current applications of S-nitrosoglutathione in anti-infective biomaterials
Hu, Q., Ye, Z., Pi, L., & Ao, J. (2022) · Materials Today Bio · doi:10.1016/j.mtbio.2022.100419 · Cited by 28
Inhibition of Platelet Function by the Endothelium
Beaulieu, L. M., & Freedman, J. E. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-387837-3.00017-1 · Cited by 26
Functional Tetrahydrobiopterin Synthesis in Human Platelets
Franscini, N., Bächli, E., Blau, N., Fischler, M., Walter, R. B., Schaffner, A., & Schoedon, G. (2004) · Circulation · doi:10.1161/01.cir.0000134281.82972.57 · Cited by 25
Martelli, A., Breschi, M. C., & Calderone, V. (2009) · Current Pharmaceutical Design · doi:10.2174/138161209787315611 · Cited by 26
Hracskó, Z., Hermesz, E., Ferencz, Á., Orvos, H., Novàk, Z., Pál, A., & Varga, I. (2009) · PubMed · Cited by 25
Lian, S., Lu, Y., Cheng, Y., Yu, T., Xie, X., Liang, H., Ye, Y., & Jia, L. (2016) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2016.08.018 · Cited by 25
de Meirelles, L. R., Mendes‐Ribeiro, A. C., Santoro, M. M., Mendes, M. A. P., Silva, M. N. D., Mann, G. E., & Brunini, T. M. C. (2007) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2007.04712.x · Cited by 26
McMichael, M. (2005) · Journal of Veterinary Emergency and Critical Care · doi:10.1111/j.1476-4431.2005.04021.x · Cited by 25
Browne, D., Meeking, D. R., Shaw, K. M., & Cummings, M. H. (2003) · The British Journal of Diabetes · doi:10.1177/14746514030030010401 · Cited by 24
Wajih, N., Liu, X., Shetty, P., Basu, S., Wu, H., Hogg, N., Patel, R. P., Furdui, C. M., & Kim‐Shapiro, D. B. (2016) · Redox Biology · doi:10.1016/j.redox.2016.04.004 · Cited by 25
Effects of Virgin Olive Oil and Phenol-Enriched Virgin Olive Oils on Lipoprotein Atherogenicity
Farràs, M., Canyelles, M., Fitó, M., & Escolá‐Gil, J. C. (2020) · Nutrients · doi:10.3390/nu12030601 · Cited by 25
Winnersbach, P., Hosseinnejad, A., Breuer, T., Fechter, T., Jakob, F., Schwaneberg, U., Rossaint, R., Bleilevens, C., & Singh, S. (2022) · Membranes · doi:10.3390/membranes12010073 · Cited by 24
Endothelial NOS-Mediated Relaxations of Isolated Thoracic Aorta of the C57BL/6J Mouse
Horváth, B., Örsy, P., & Benyó, Z. (2005) · Journal of Cardiovascular Pharmacology · doi:10.1097/01.fjc.0000154377.90069.b9 · Cited by 24
Effects of Bak Foong Pill on Blood Coagulation and Platelet Aggregation.
Gou, Y., Ho, A. L. S., Rowlands, D. K., Chung, Y. W., & Chan, H. C. (2003) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.26.241 · Cited by 24
Bolla, M., Momi, S., Gresele, P., & Soldato, P. D. (2005) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-005-0026-6 · Cited by 24
Moreira, L. D. S. G., Fanton, S., Cardozo, L., Borges, N. A., Combet, E., Shiels, P. G., Stenvinkel, P., & Mafra, D. (2021) · Nutrition Reviews · doi:10.1093/nutrit/nuab074 · Cited by 23
Platelet proteomics in cardiovascular diseases
Vélez, P., & García, Á. G. (2014) · Translational Proteomics · doi:10.1016/j.trprot.2014.09.002 · Cited by 23
Zotti, F. D., Lobysheva, I. I., & Balligand, J. (2018) · PLoS ONE · doi:10.1371/journal.pone.0200352 · Cited by 23
Effect of hypercholesterolemia and of oxidative stress on the nitric oxide-cGMP pathway
Francois, M., & Kojda, G. (2004) · Neurochemistry International · doi:10.1016/j.neuint.2004.03.026 · Cited by 23
An experiment of nature: genetic l-arginine deficiency and NO insufficiency
Loscalzo, J. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13848 · Cited by 23
Self-citationNitric Oxide and Other Novel Therapies for Pulmonary Hypertension
Claudio Napoli, A., & Loscalzo, J. (2004) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/107424840400900i101 · Cited by 23
Self-citationEstrogen therapy and thrombotic risk
Miller, V. M., Jayachandran, M., Heit, J. A., & Owen, W. G. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2006.01.001 · Cited by 23
Shah, K. A., White, T. G., Powell, K., Woo, H. H., Narayan, R. K., & Li, C. (2022) · Neurosurgery · doi:10.1227/neu.0000000000001854 · Cited by 22
Nitric Oxide Dysregulation in Platelets from Patients with Advanced Huntington Disease
Carrizzo, A., Pardo, A. D., Maglione, V., Damato, A., Amico, E., Formisano, L., Vecchione, C., & Squitieri, F. (2014) · PLoS ONE · doi:10.1371/journal.pone.0089745 · Cited by 22
Anfossi, G., Russo, I., Massucco, P., Mattiello, L., & Trovati, M. (2003) · Thrombosis Research · doi:10.1016/s0049-3848(03)00284-6 · Cited by 22
Current molecular aspects in the development and treatment of diabetes
Álvarez-Almazán, S., Filisola-Villaseñor, J. G., Alemán-González-Duhart, D., Cach, F. T., & Mendieta‐Wejebe, J. E. (2020) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-019-00717-0 · Cited by 22
Schäfer, A., Fraccarollo, D., Vogt, C., Flierl, U., Hemberger, M., Tas, P. W. L., Ertl, G., & Bauersachs, J. K. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.01.013 · Cited by 22
Prothrombotic determinants of coronary atherothrombosis
Ruberg, F. L., & Loscalzo, J. (2002) · Vascular Medicine · doi:10.1191/1358863x02vm448ra · Cited by 22
Self-citationBaum, C., Johannsen, S. S., Zeller, T., Atzler, D., Ojeda, F. M., Wild, P. S., Sinning, C. R., Lackner, K. J., Gori, T., Schwedhelm, E., et al. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.10.101 · Cited by 21
Peck, M. J., Sanders, E. B., Scherer, G., Lüdicke, F., & Weitkunat, R. (2018) · Biomarkers · doi:10.1080/1354750x.2017.1419284 · Cited by 21
Hines, P. C., Callaghan, M. U., Zaidi, A. U., Gao, X., Liu, K., White, J. U., & Tarasev, M. (2021) · British Journal of Haematology · doi:10.1111/bjh.17643 · Cited by 21
Nitric oxide: A potential etiological agent for vaso-occlusive crises in sickle cell disease
Gupta, P., & Kumar, R. (2024) · Nitric Oxide · doi:10.1016/j.niox.2024.01.008 · Cited by 21
Bon, E. D., Bonanni, G., Saggiorato, G., Bassi, P., & Cella, G. (2010) · Angiology · doi:10.1177/0003319710362977 · Cited by 21
Platelet Redox Balance in Diabetic Patients With Hypertension Improved by n-3 Fatty Acids
McDonald, D., O’Kane, F., McConville, M., Devine, A. B., & McVeigh, G. E. (2012) · Diabetes Care · doi:10.2337/dc12-0304 · Cited by 21
Effects of nitrite and far-red light on coagulation
Wajih, N., Alipour, E., Rigal, F. J., Zhu, J., Perlegas, A. S., Caudell, D. L., & Kim‐Shapiro, D. B. (2020) · Nitric Oxide · doi:10.1016/j.niox.2020.11.005 · Cited by 21
Should hyperhomocysteinemia be treated in patients with atherosclerotic disease?
Maron, B. A., & Loscalzo, J. (2007) · Current Atherosclerosis Reports · doi:10.1007/s11883-007-0048-x · Cited by 22
Self-citationMarder, W., Somers, E. C., Kaplan, M. J., Anderson, M. D., Lewis, E., & McCune, W. J. (2010) · Lupus · doi:10.1177/0961203310371156 · Cited by 21
The Role of Oxidative Stress in Endothelial Dysfunction and Vascular Inflammation
Osto, E., & Cosentino, F. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-373866-0.00022-8 · Cited by 23
Metadata
- Authors
- Loscalzo, J.
- Affiliations
- Boston University (US)
- Corresponding author
- Loscalzo, Joseph
- ORCID
- Loscalzo, Joseph
- Venue
- Circulation Research
- Published
- 2001-04-27
- Volume
- 88
- Issue
- 8
- Pages
- 756-762
- ISSN
- 0009-7330 (ISSN-L)
- 1524-4571
- OpenAlex
- W2113684546
- Cited by
- 612
- References
- 80
- Citations by year
- 2026: 18 · 2025: 21 · 2024: 22 · 2023: 21 · 2022: 22 · 2021: 19 · 2020: 25 · 2019: 15 · 2018: 28 · 2017: 25 · 2016: 16 · 2015: 24 · 2014: 27 · 2013: 28 · 2012: 29
- FWCI
- 3.28
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Circulation Research (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Heart, Lung, and Blood Institute (HL61795, HL 55993, HL58976, R01HL058976, P50HL055993)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Health Sciences › Medicine › Hematology › Platelet Disorders and Treatments
- Health Sciences › Medicine › Hematology › Blood Coagulation and Thrombosis Mechanisms
- Keywords
- nitric oxide, platelet activation, arterial thrombosis, endothelial dysfunction, glutathione peroxidase 3, phosphatidylinositol 3-kinase, cyclooxygenase-1, guanylate cyclase, platelet aggregation, thromboprophylaxis
- MeSH terms
- Animals, Arteries, Blood Platelets, Endothelium, Vascular, Glutathione Peroxidase, Humans, Nitric Oxide, Thrombosis, Vasodilator Agents, Platelet Activation, Reactive Oxygen Species, Nitric Oxide Donors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review